CRISPR-LbCpf1 prevents choroidal neovascularization in a mouse model of age-related macular degeneration
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
CRISPR-LbCpf1 prevents choroidal neovascularization in a mouse model of age-related macular degeneration ; volume:9 ; number:1 ; day:10 ; month:5 ; year:2018 ; pages:1-8 ; date:12.2018
Nature Communications ; 9, Heft 1 (10.5.2018), 1-8, 12.2018
- Creator
-
Koo, Taeyoung
- Contributor
-
Park, Sung Wook
Jo, Dong Hyun
Kim, Daesik
Kim, Jin Hyoung
Cho, Hee-Yeon
Kim, Jeungeun
Kim, Jeong Hun
Kim, Jin-Soo
SpringerLink (Online service)
- DOI
-
10.1038/s41467-018-04175-y
- URN
-
urn:nbn:de:101:1-2018070800562328264947
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Koo, Taeyoung
- Park, Sung Wook
- Jo, Dong Hyun
- Kim, Daesik
- Kim, Jin Hyoung
- Cho, Hee-Yeon
- Kim, Jeungeun
- Kim, Jeong Hun
- Kim, Jin-Soo
- SpringerLink (Online service)
Other Objects (12)
Choroidal Modifications Preceding the Onset of Macular Neovascularization in Age-Related Macular Degeneration
Mast cells promote choroidal neovascularization in a model of age-related macular degeneration
Activation of a Quiescent Choroidal Neovascularization in a Patient with Age-Related Macular Degeneration
Optical Coherence Tomography Prognostic Factors in Age-Related Macular Degeneration Patients with Peripapillary Choroidal Neovascularization
Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration
Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Current Perspectives on Type 3 Macular Neovascularization due to Age-Related Macular Degeneration
Brolucizumab for recalcitrant macular neovascularization in age-related macular degeneration with pigment epithelial detachment
Correction to: Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Longitudinal Changes in Choroidal Thickness and Choroidal Vascularity Index in Age-Related Macular Degeneration
Inflammasome activation aggravates choroidal neovascularization
Outer nuclear layer recovery as a predictor of visual prognosis in type 1 choroidal neovascularization of neovascular age-related macular degeneration
Choroidal Modifications Preceding the Onset of Macular Neovascularization in Age-Related Macular Degeneration
Mast cells promote choroidal neovascularization in a model of age-related macular degeneration
Activation of a Quiescent Choroidal Neovascularization in a Patient with Age-Related Macular Degeneration
Optical Coherence Tomography Prognostic Factors in Age-Related Macular Degeneration Patients with Peripapillary Choroidal Neovascularization
Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration
Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Current Perspectives on Type 3 Macular Neovascularization due to Age-Related Macular Degeneration
Brolucizumab for recalcitrant macular neovascularization in age-related macular degeneration with pigment epithelial detachment
Correction to: Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Longitudinal Changes in Choroidal Thickness and Choroidal Vascularity Index in Age-Related Macular Degeneration
Inflammasome activation aggravates choroidal neovascularization
Outer nuclear layer recovery as a predictor of visual prognosis in type 1 choroidal neovascularization of neovascular age-related macular degeneration
Choroidal Modifications Preceding the Onset of Macular Neovascularization in Age-Related Macular Degeneration
Mast cells promote choroidal neovascularization in a model of age-related macular degeneration
Activation of a Quiescent Choroidal Neovascularization in a Patient with Age-Related Macular Degeneration
Optical Coherence Tomography Prognostic Factors in Age-Related Macular Degeneration Patients with Peripapillary Choroidal Neovascularization
Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration
Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Current Perspectives on Type 3 Macular Neovascularization due to Age-Related Macular Degeneration
Brolucizumab for recalcitrant macular neovascularization in age-related macular degeneration with pigment epithelial detachment
Correction to: Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Longitudinal Changes in Choroidal Thickness and Choroidal Vascularity Index in Age-Related Macular Degeneration
Inflammasome activation aggravates choroidal neovascularization